Ter Beek W Pascale, Muller Eveline S M, van den Berg Marlies, Meijer Martin J, Biemond Izäk, Lamers Cornelis B H W
Department of Gastroenterology-Hepatology, Leiden University Medical Centre, The Netherlands.
Inflamm Bowel Dis. 2008 May;14(5):612-9. doi: 10.1002/ibd.20364.
Besides regulation of upper gastrointestinal motility, motilin seems to play a role in the inflammatory response. Motilin receptor expression in human intestine has not been studied thoroughly. This study aimed to describe the intestinal distribution of motilin receptors in inflammatory bowel disease (IBD) and control patients.
Quantitative autoradiography, immunohistochemistry, and reverse-transcriptase polymerase chain reaction (RT-PCR) were used to detect motilin receptors in tissue of 25 IBD patients (13 Crohn's disease [CD], 12 ulcerative colitis [UC]) and 19 patients with a neoplasm (controls).
Median muscular motilin binding was 3 and 8 fmol/g tissue in colon and ileum, respectively. In the gastroduodenal region the median was higher (93 fmol/g). In UC colonic muscular motilin binding was significantly increased compared to controls (7 vs. 3 fmol/g, P < or = 0.05). Expression in CD was similar to controls. Besides the binding found in the muscular compartment, motilin binding was also found in the mucosa, which was even higher than in the muscle (3 versus 11 and 8 versus 27 fmol/g for colon and ileum (P < or = 0.06), respectively). RT-PCR and immunohistochemistry confirmed the mucosal motilin receptor expression. The mucosal motilin receptors were located in the epithelial cells. In the muscular compartment receptors were strongly present in the myenteric plexus and weakly in the smooth muscle cells. In IBD tissue the expression pattern was not different.
The motilin receptor is expressed in human colonic and ileal smooth muscle. Further, motilin receptor expression was also shown in the mucosa. Muscular binding in UC patients is increased but no different expression pattern was found.
胃动素除了调节上消化道运动外,似乎还在炎症反应中发挥作用。人肠道中胃动素受体的表达尚未得到充分研究。本研究旨在描述炎症性肠病(IBD)患者和对照患者中胃动素受体的肠道分布。
采用定量放射自显影、免疫组织化学和逆转录聚合酶链反应(RT-PCR)检测25例IBD患者(13例克罗恩病[CD],12例溃疡性结肠炎[UC])和19例肿瘤患者(对照)组织中的胃动素受体。
结肠和回肠肌肉中胃动素结合的中位数分别为3和8 fmol/g组织。在胃十二指肠区域,中位数更高(93 fmol/g)。与对照相比,UC患者结肠肌肉中胃动素结合显著增加(7 vs. 3 fmol/g,P≤0.05)。CD患者的表达与对照相似。除了在肌肉部分发现的结合外,在黏膜中也发现了胃动素结合,其甚至高于肌肉中的结合(结肠和回肠分别为3 vs. 11和8 vs. 27 fmol/g,P≤0.06)。RT-PCR和免疫组织化学证实了黏膜中胃动素受体的表达。黏膜胃动素受体位于上皮细胞中。在肌肉部分,受体在肌间神经丛中大量存在,在平滑肌细胞中少量存在。在IBD组织中,表达模式没有差异。
胃动素受体在人结肠和回肠平滑肌中表达。此外,在黏膜中也显示有胃动素受体表达。UC患者的肌肉结合增加,但未发现不同的表达模式。